51% sales increase to EUR 9.8 million in the first quarter 2012

Berlin, (PresseBox) - Preliminary figures indicate that aap Implantate AG (XETRA: AAQ.DE), a global medical device company focused on innovative trauma products and biomaterials for the orthopaedic market, achieved total sales in the first quarter of 2012 of EUR 9.8 million, a 51% increase on the previous year's figure of EUR 6.5 million. The sales growth was driven by an 18% increase in sales on product level to EUR 7.7 million (previous year: EUR 6.5 million) as well as from the sales of EUR 2.1 million from the exclusive license agreement with a world-leading medical technology company announced on March 23, 2012.

Based on the sales on product level in the first quarter 2012 and the Company's goal of achieving profitable growth, the Company anticipates that EBITDA growth on product level in the first quarter 2012 will be stronger than the sales increase on product level. In addition, based on the sales on product level for the first quarter 2012, the management board of aap is reiterating its full year 2012 outlook for a 10% sales increase on product level.

The Company's Q1 2012 report is scheduled for publication on May 15, 2012.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.